SIG Asia-backed pet lifestyle goods provider has secured funding in a round led by ClearVue Partners with the aim of driving international expansion.

Alexandria Venture Investments was among the participants in the neurological disease drug developer's series B round.

The medical data provider has now secured almost $78m in total, with Novartis and Qualcomm venture DRx Capital returning for its series B round.

L3Harris Technologies participated in a series B round for microwave-based defence technology developer Epirus following a $17m round last year.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Binance Labs co-led the multi-chain crypto wallet developer's series B round following $7.8m in funding last month.

Existing investor General Motors led a round that will support the car maintenance and refueling provider's expansion and recruitment.

Neurodegenerative disease management platform Octave Bioscience has now raised more than $48m in total, Blue Venture Fund and Echo Health Ventures backing its latest round.

Biopharmaceutical company Origenis helped form the neurological and immunological disease drug developer, which has revealed series A and B funding.

The clinical data management platform boosted its total funding to $30m in a Centene-led series B round featuring Optum Ventures.